The appearance of ovarian lesions on ultrasound may predict the risk for malignancy, according to a study published in the June issue of Radiology.
May 27, 2022
0
3
When a 41-year-old woman was diagnosed with chronic-phase chronic myeloid leukemia, she received a bone marrow transplant and subsequent leukocyte infusion from her sister. These treatments controlled her leukemia, but seven ...
Dec 12, 2011
0
0
A computer program easily run on a tablet or a smartphone that compares a spot on a patient's skin to images of both benign and malignant lesions may be a useful, noninvasive tool for physicians when deciding when to do a ...
Oct 1, 2015
0
52
Researchers at Queen Mary University of London have developed the world's first PCR test for mouth cancer. The test has now been proved with patients from China, India and the UK, with the results published in the international ...
Mar 22, 2022
0
140
Breast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major cancers, it is the only one that has shown an increasing trend over the past 20 years.
Mar 8, 2023
0
5
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade ...
Feb 16, 2012
0
0
(HealthDay)—Multiple bilateral (MB) circumscribed breast masses detected with ultrasound screening are almost always benign, according to research published in the September issue of Radiology.
Sep 17, 2013
0
0
Genomic instability caused by an erosion of the protective caps on chromosomes, followed by activation of an enzyme that reinforces those caps, allows malignant cells to evade destruction and acquire more deadly characteristics, ...
Feb 21, 2012
0
0
Screening for lung cancer with low dose CT scans has been shown to save lives. However, research shows that when CT scans reveal nodules in the lungs, it is not cancerous 96 percent of the time. As a result, scientists are ...
Apr 15, 2012
0
0
Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with ...
Aug 6, 2015
0
5
